Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 156 resultados

ACROBAT Newborns: Appraising the Critical Role of prognostic Biomarkers in the Assessment and Triage of sick African n... The main concern of clinicians when addressing sick patients is to promptly identify -i.e., not miss- those at higher risk of severe disease...
2024-10-28 - 2029-12-31 | Financiado

SOFAR: SOuthern aFrica research cApacity netwoRk The SOuthern aFrica Research cApacity netwoRk (SOFAR) will train a generation of innovative world class and resilient African scientists, cl...
2024-09-13 - 2029-03-31 | Financiado

INTERCAMBIO: Interventions to promote mental and physical health in changing working environments due to climate... LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER participó en un HORIZON EUROPE: HORIZON-HLTH-2023-ENVHLTH-02 Work environments are rapidly changing in Europe. The COVID-19 pandemic resulted in an acceleration of a range of complex and multidimension...
2023-11-10 - 2028-12-31 | Financiado

MOBILE MEN: Implementing oral and long acting Pre exposure prophylaxis in mobile men in Sub Saharan Africa MOB... LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER participó en un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2022-01 Reducing HIV is key 2030 SDG target. In Africa, HIV prevention research has focused on young women yet heterosexual men, vulnerable due to t...
2023-06-22 - 2026-06-30 | Financiado

EChiLiBRiST: Development and validation of a quantitative point of care test for the measurement of severity biom... LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER participó en un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 "Fever is the leading reason to seek healthcare globally, with over 1 billion cases of febrile illness occurring in children annually. The v...
2022-07-18 - 2027-08-31 | Financiado

PvSTATEM: SEROLOGICAL TESTING AND TREATMENT FOR P. VIVAX: FROM A CLUSTER-RANDOMISED TRIAL IN ETHIOPIA AND MADA... LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER participó en un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 P. vivax is considered the most difficult human malaria to eliminate because of the inability of conventional diagnostics to detect individu...
2022-05-24 - 2027-09-30 | Financiado

WorldFAIR: Global cooperation on FAIR data policy and practice LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER participó en un HORIZON EUROPE: HORIZON-WIDERA-2021-ERA-01 CODATA and RDA will work with a set of domain and cross-domain case studies to implement and test FAIR recommendations, including those for...
2022-05-10 - 2024-05-31 | Financiado

CAMERA: Causes and MEchanisms foR non atopic Asthma in children LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER tramitó un H2020: ERC-2020-ADG Until 20 years ago it was widely believed that asthma was an allergic/atopic disease involving atopic inflammation of the airways. Work that...
2021-08-21 - 2026-09-30 | Financiado

UNITE4TB: ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER participó en un H2020: H2020-JTI-IMI2-2020-20-two-stage Current anti-tuberculosis (TB) drug regimens face serious limitations at times of increasing antimicrobial drug resistance. Fortunately, for...
2021-06-29 - 2028-05-31 | Financiado

MORDIC: Mortality Risk Attributable to Thermal Discomfort Indicators with Implications of Climate Change LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER tramitó un H2020: H2020-MSCA-IF-2020 A rapidly growing body of studies attribute mortality outcomes to thermal exposures, by empirically estimating reduced-form mortality respon...
2021-03-12 - 2024-08-31 | Financiado

RIVER-EU: Reducing Inequalities in Vaccine uptake in the European Region Engaging Underserved communities LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER participó en un H2020: H2020-SC1-BHC-2018-2020 Health system barriers in vaccine uptake disproportionately affect specific ethnic, religious or cultural minorities across Europe and are t...
2021-03-12 - 2026-05-31 | Financiado

CBIG-SCREEN: Working collaboratively with vulnerable women to identify the best implementation gains by screening... LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER participó en un H2020: H2020-SC1-BHC-2018-2020 CBIG-SCREEN aims to tackle inequality in cervical cancer screening (CCS) continuum. Though CCS programmes drastically reduce cervical cancer...
2021-02-02 - 2026-02-28 | Financiado

ENBEL: Enhancing Belmont Research Action to support EU policy making on climate change and health LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER participó en un H2020: H2020-LC-CLA-2018-2019-2020 ENBEL will support EU policy making by bringing together leaders in climate change and health research. We do so by coordinating a network o...
2020-09-30 - 2024-01-31 | Financiado

TRANSVAC-DS: DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER participó en un H2020: H2020-SC5-2018-2019-2020 The TRANSVAC-DS project further builds on the outstanding success of EC-funded projects:TRANSVAC1 and TRANSVAC2 and proposes the establishme...
2020-06-09 - 2023-02-28 | Financiado

CAGECONTROL: Identification and manipulation of factors that control Shigella flexneri entrapment in septin cages... LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER tramitó un H2020: H2020-MSCA-IF-2019 Shigella is a Gram-negative bacterial pathogen and causative agent of bacillary dysentery (also called shigellosis). Shigella kills ∼164 tho...
2020-04-16 - 2023-01-31 | Financiado

EpiPose: Epidemic intelligence to minimize 2019 nCoV s public health economic and social impact in Europe LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER participó en un H2020: H2020-SC1-PHE-CORONAVIRUS-2020 EpiPose aims to provide urgently needed answers about the epidemiological characteristics of 2019-nCoV, the social dynamics of the outbreak,...
2020-04-08 - 2023-04-12 | Financiado

DIAMONDS: Diagnosis and Management of Febrile Illness using RNA Personalised Molecular Signature Diagnosis LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER participó en un H2020: H2020-SC1-BHC-2018-2020 Our proposal will address the challenge of bringing personalised medicine into routine use in EU healthcare systems for diagnosis and treatm...
2019-12-06 - 2025-06-30 | Financiado

LSHTM